Annual consumption by region (tonnes)
* These figures are approximate, actual numbers may slightly vary due to differences in data collection timeline, definitions, and reporting year.
Regions with high antimicrobial resistance prevalence
E. coli, K. pneumoniae
Resistance rate: 65%
Salmonella, Shigella
Resistance rate: 58%
M. tuberculosis, S. pneumoniae
Resistance rate: 45%
Acinetobacter, P. aeruginosa
Resistance rate: 42%
S. aureus, Enterococcus
Resistance rate: 40%
MRSA, C. difficile, E. coli, S. pneumoniae
Resistance rate: 32%
Global impact of antimicrobial resistance
700,000
10 million
$100 trillion
41
73%
65%
144
$55 billion
40-50%
30%
500,000
75%
49.6 billion DDDs
13%
€11.7 billion
Recent breakthroughs in antimicrobial resistance research
Researchers at Roche have discovered a novel antibiotic effective against carbapenem-resistant Acinetobacter baumannii (CRAB), one of the most dangerous superbugs.
Impact: First new class of antibiotics for Gram-negative bacteria in over 50 years, potentially saving thousands of lives annually.
Scientists at MIT and Harvard have developed a machine learning algorithm that can predict antibiotic resistance with 96% accuracy using bacterial genome sequences.
Impact: Enables rapid resistance detection in under 3 hours, compared to traditional 1-2 day culture methods, allowing for faster appropriate treatment.
A phase II clinical trial showed 75% success rate for bacteriophage therapy in treating multi-drug resistant infections that had failed conventional antibiotic treatment.
Impact: Provides alternative treatment option for otherwise untreatable infections, potentially reducing mortality rates by up to 40% in severe cases.
The WHO's Global Antimicrobial Resistance and Use Surveillance System (GLASS) has expanded to include 127 countries, now covering 72% of the world's population.
Impact: Improved global monitoring enables better targeted interventions and policy development, potentially preventing 165,000 deaths annually.
A multi-center study across 152 hospitals implementing a novel antibiotic stewardship program showed a 32% reduction in inappropriate antibiotic prescribing.
Impact: Reduced hospital-acquired infections by 26% and decreased antibiotic resistance rates by 18% over a 3-year period.
References for the information presented in this dashboard
| Source Name | URL |
|---|---|
| World Health Organization (WHO) | https://www.who.int/health-topics/antimicrobial-resistance |
| Centers for Disease Control and Prevention (CDC) | https://www.cdc.gov/drugresistance/index.html |
| European Centre for Disease Prevention and Control (ECDC) | https://www.ecdc.europa.eu/en/antimicrobial-resistance |
| The Review on Antimicrobial Resistance | https://amr-review.org/ |
| Global Antibiotic Research and Development Partnership (GARDP) | https://gardp.org/ |